Christian T Farrar Selected Research

Fibrosis (Cirrhosis)

1/2020	Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
1/2020	Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI.
7/2018	Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist.
1/2018	CM-101: Type I Collagen-targeted MR Imaging Probe for Detection of Liver Fibrosis.
1/2017	Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model.
9/2015	3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian T Farrar Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 05/2009
6	Fibrosis (Cirrhosis) 01/2020 - 09/2015
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2009
4	Liver Cirrhosis (Hepatic Cirrhosis) 07/2018 - 09/2015
2	Necrosis 04/2016 - 11/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 11/2011
2	Amyloid Plaque 01/2014 - 11/2011
2	Stroke (Strokes) 06/2013 - 04/2013
2	Brain Neoplasms (Brain Tumor) 11/2012 - 05/2009
2	Breast Neoplasms (Breast Cancer) 11/2012 - 10/2012
2	Glioma (Gliomas) 03/2011 - 07/2010
2	Edema (Dropsy) 03/2011 - 05/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Nephrogenic Fibrosing Dermopathy 01/2017
1	Cardiotoxicity 01/2017
1	Herpes Simplex 06/2015
1	Hypercapnia 04/2013
1	Medulloblastoma 02/2013
1	Brain Edema (Cerebral Edema) 07/2010
1	Myocardial Infarction 06/2008
1	Ischemia 12/2007
1	Lactic Acidosis 12/2007
1	Brain Ischemia (Cerebral Ischemia) 09/2007
1	Insulin Resistance 06/2007

Drug/Important Bio-Agent (IBA)

5	CollagenIBA 01/2020 - 05/2009
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2016 - 05/2009
5	Biomarkers (Surrogate Marker)IBA 09/2013 - 05/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2015
4	Collagen Type I (Type I Collagen)IBA 01/2020 - 09/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 05/2009
3	Contrast MediaIBA 01/2020 - 11/2011
3	GadoliniumIBA 01/2018 - 11/2011
3	cediranib (AZD2171)IBA 04/2016 - 05/2009
2	Protons (Proton)IBA 10/2021 - 12/2007
2	AmidesIBA 10/2021 - 12/2007
2	Lysine (L-Lysine)FDA Link 11/2020 - 06/2015
2	streptococcal polysaccharide type III group BIBA 01/2020 - 01/2018
2	Hydroxyproline (4 Hydroxyproline)IBA 07/2018 - 09/2015
2	Messenger RNA (mRNA)IBA 07/2018 - 09/2007
2	Pharmaceutical PreparationsIBA 01/2017 - 11/2012
2	Gadolinium DTPA (Magnevist)FDA Link 06/2013 - 10/2012
1	folfirinoxIBA 01/2020
1	allysineIBA 01/2020
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2020
1	EDP-305IBA 07/2018
1	MineralsIBA 01/2017
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	MEDI3617IBA 04/2016
1	Sirolimus (Rapamycin)FDA Link 09/2015
1	Nucleotide AptamersIBA 01/2014
1	Biological ProductsIBA 09/2013
1	SolutionsIBA 04/2013
1	Neuropilin-1IBA 02/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2013
1	Epidermal Growth Factor (EGF)IBA 11/2012
1	Trastuzumab (Herceptin)FDA Link 11/2012
1	Lapatinib (GW572016)FDA Link 11/2012
1	EP-2104RIBA 10/2012
1	FibrinIBA 10/2012
1	Peptides (Polypeptides)IBA 10/2012
1	Coloring Agents (Dyes)IBA 11/2011
1	Indicators and Reagents (Reagents)IBA 11/2011
1	Tumor Biomarkers (Tumor Markers)IBA 03/2011
1	Angiopoietin-2IBA 07/2010
1	Phosphotransferases (Kinase)IBA 05/2009
1	Endothelial Growth FactorsIBA 05/2009
1	monocrystalline iron oxide nanoparticle (MION)IBA 06/2008
1	APTIBA 12/2007
1	Actins (F Actin)IBA 09/2007
1	Stavudine (Zerit)FDA LinkGeneric 06/2007
1	Mitochondrial DNA (mtDNA)IBA 06/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2007

Therapy/Procedure

11	Therapeutics 01/2022 - 04/2010
2	Oncolytic Virotherapy 01/2022 - 11/2020
1	Neoadjuvant Therapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2017
1	Ligation 09/2015